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Abstract
Background: Methanolic, aqueous and Total Oligomer Flavonoids (TOF)-enriched extracts obtained from the leaves
of Acacia salicina ’Lindl.’ were investigated for antibacterial, antimutagenic and antioxidant activities.
Methods: The antimicrobial activity was tested on the Gram positive and Gram negative reference bacterial strains.
The Mutagenic and antimutagenic activities against direct acting mutagens, methylmethane sulfonate (MMS) and
4-nitro-o-phenylenediamine (NOPD), and indirect acting mutagens, 2-aminoanthracene (2-AA) and benzo[a]pyrene
(B(a)P) were performed with S. typhimurium TA102 and TA98 assay systems. In addition, the enzymatic and
nonenzymatic methods were employed to evaluate the anti-oxidative effects of the tested extracts.
Results: A significant effect against the Gram positive and Gram negative reference bacterial strains was observed
with all the extracts. The mutagenic and antimutagenic studies revealed that all the extracts decreased the
mutagenicity induced by B(a)P (7.5 μg/plate), 2-AA (5 μg/plate), MMS (1.3 mg/plate) and NOPD (10 μg/plate).
Likewise, all the extracts showed an important free radical scavenging activity towards the superoxide anion
generated by the xanthine/xanthine oxidase assay system, as well as high Trolox Equivalent Antioxidant Capacity
(TEAC), against the 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS)
+￿ radical. TOF-
enriched extract exhibited the highest protective effect against free radicals, direct acting-mutagen and
metabolically activated S9-dependent mutagens.
Conclusions: The present study indicates that the extracts from A. salicina leaves are a significant source of
compounds with the antimutagenic and antioxidant activities, and this may be useful for developing potential
chemopreventive substances.
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Background
Plants are rich source of natural products used for centu-
ries to cure various diseases. The plant-derived medicines
are based upon the premise that they contain natural sub-
stances that can promote health and alleviate illness. So, a
retrospection of the healing power of plants and a return
to natural substances are an absolute need of our time.
The demonstration of the presence of natural products,
such as polyphenols, alkaloids, flavonoids, coumarins and
other secondary metabolites in medicinal plants will pro-
v i d eas c i e n t i f i cv a l i d a t i o nf o rt h ep o p u l a ru s eo ft h e s e
plants [1].
Acacia (Fabaceae) is an evergreen tree that is native of
Australia, but it is now widely distributed in the Mediter-
ranean area. Acacia is a large genus comprising more than
700 species. The genus Acacia is frequently used for the
treatment of various illnesses because of their reputed
pharmacological effects; published informations indicate
that Acacia has hypoglycemic [2], antibacterial [3], anti-
inflammatory [4], cestocidal [5], spasmogenic and vaso-
constrictor [6], antihypertensive and antispasmodic activ-
ities [7], anti-aggregation platelet effect [8], as well as an
inhibitory effect against hepatitis C virus [9]. In Tunisian
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the species and according to the region. Based on informa-
tions gathered from traditional healers, herbalists, and
inhabitants of rural south Tunisia, Acacia salicina has fre-
quently been used as a the treatment of several diseases,
such as the treatment of inflammatory diseases, as “febri-
fuge” to treat cancer, and as a fertility enhancer. In the
south Tunisia, infusions prepared from fresh or dried
leaves are taken orally, or alternatively, chopped fresh
leaves are applied directly on inflamed sores. Traditional
medical uses of Acacia in the north Tunisia are somewhat
different [10].
Some Acacia species, and among them Acacia sali-
cina, were described to be rich in tannins. Tannins
obtained from A. salicina were reported to be responsi-
ble for the microbial activity [11].
Hence, in this paper we examined the antimicrobial,
antimutagenic, and antioxidant activities of polar
extracts obtained from Acacia salicina leaves. Our study
revealed an interaction between the secondary metabo-
lite composition of extracts, and each radical and/or
bacterial strain used in the different assays.
Results and discussion
Antimicrobial activity
The antibacterial activity of the three tested A. salicina leaf
extracts was evaluated on five pathogenic bacteria. Our
results showed that these extracts exhibited various levels
of antibacterial effect against all the tested bacterial strains.
Minimum Inhibitory Concentration (MICs) values ranged
from 0.0625 to over 10 mg/ml, and Minimum Bactericidal
Concentration (MBCs) values ranged from 0.125 to more
than 10 mg/ml. Generally, TOF extract displayed a strong
activity against both Gram-negative and Gram-positive
bacteria. The result of the antimicrobial activity is pre-
sented in Table 1.
Staphylococcus aureus was the most susceptible bacter-
ial species, followed by Salmonella typhimurium,t h e n
Salmonella enteritidis and Enterococcus faecalis and
finally Escherichia coli, with MIC values of 0.062, 0.125,
0.250, 0.250 and > 10 mg/ml respectively. Compared to
ampicillin, used as a positive control against S. aureus
(0.225 mg/ml), the tested TOF extract was twice more
active with MBC value of 0.125 mg/ml. E. coli was found
to be the least sensitive strain to A. salicina extracts.
C o m p a r e dt ot h eo t h e re x t r a c t s ,T O Fe x t r a c tw a st h e
most active one against all the tested bacterial strains. Its
biological efficiency is probably related to the high
amounts of flavonoids and polyphenolic compounds, in
its chemical composition. We previously reported, that
A. salicina extracts, particularly TOF extract, contains
flavonoidic, polyphenolic and coumarinic compounds
[12]. These families of compounds are reported to play a
role in the prevention of colonisation by parasites,
bacteria and fungi [13].
Our results indicate that Gram-positive bacteria are
more sensitive to the antimicrobial effect of A. salicina
extracts than Gram-negative ones. It is interesting to note
that A. salicina extracts exhibited an antimicrobial activity,
particularly towards organisms of interest to the medical
field such as Staphylococci, Enterococci and Salmonella.I n
fact, Salmonella remains a primary cause of food poison-
ing worldwide, and massive outbreaks have been reported
in recent years. The centre for disease control and preven-
tion estimated that approximately 1.4 million cases of sal-
monellosis were annually reported in the United States
[14]. The European Union reported more than 100.000
cases of salmonellosis [15]. In Tunisia, between 1978 and
1993, 1022 Salmonella strains were isolated: 578 in hospi-
tals and 444 from the environment [16]. Some pathogenic
Salmonella serotypes adapted to man, such as S. typhi-
murium, usually cause severe diseases such as enteric
fever in humans. However, some pathogenic Salmonella
serotypes, such as S. enteritidis or S. typhimurium, can
infect a wide range of hosts and are termed ubiquitous.
Likewise, foodborne illness resulting from the consump-
tion of food contaminated with pathogenic bacteria, has
been a vital concern to public health. Salmonella spp. and
Table 1 Antibacterial activity of Acacia salicina extracts, expressed as Minimum Inhibitory Concentration (MIC) and as










a MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
Metanolic extract 1 2.5 2.5 5 > 10 > 10 2.5 5 2.5 7.5
Aqueous extract 1.25* 2.5 2.5 5 2.5 5 2.5 5 2.5 5
TOF extract 0.0625* 0.125* 0.25* 0.5* > 10 > 10 0.25* 0.5* 0.125* 0.5*
Ampicilin b 0.0015 0.225 0.0025 0.125 0.006 0.275 0.0019 0.085 0.0039 0.26
* P < 0.05 compared to negative control without the tested extract by student test.
a Values were expressed as means ± standard deviation of three experiments
b) Positive control
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and deaths.
Antioxidant activities
Radical-Scavenging activity against ABTS
+
The free radical scavenging capacity of A. salicina
extracts was evaluated using the ABTS assay (Table 2).
Decolorization of ABTS
+￿ reflects the capacity of antioxi-
dant species to donate electrons or hydrogen atoms to
inactivate this radical cation. A potential activity was
noted at the different tested concentrations of all the stu-
died extracts. The tested extracts seem to be more active
than the positive control, trolox compound, as IC50 value
obtained with trolox (0.76 mg/ml) was higher than IC50
value obtained with TOF, methanol and aqueous extracts
(0.11, 0.39 and 0.24 mg/ml respectively). In fact, the
tested extracts are complex mixtures of several com-
pounds, in particular phenolic compounds with diverse
chemical structures that determine various properties.
The antioxidant effect of polyphenols against ABTS
+. was
reported earlier [17,18], similar to our observations in the
current study. The reaction pattern consists of initial fast
scavenging activity, where more active compounds react
immediately with the radical. Products are formed, and
together with the less reactive molecules, give a second
slow reaction. The results obtained with our extracts cor-
roborate this type of kinetic behaviour in all the samples
and dilutions assayed. According to the result reported in
the Table 2.
The TEAC values obtained with the different extracts
reflect the relative ability of hydrogen or electron-donat-
ing antioxidants to scavenge the ABTS radical cation
compared to that of Trolox (Table 2). When referring to
TEAC values, TOF, aqueous and methanolic extracts
revealed potent antioxidant capacities, with TEAC values
of 1.92, 2.19 and 1.65 mM respectively. The values largely
exceed the TEAC of the positive control Trolox (1 mM).
Effects on superoxide anion generating system
The antioxidant activity of A. salicina leaf extracts was
evaluated by the xanthine oxydase enzymatic system. The
influence of A. salicina leaf extracts on XOD activity
and/or the superoxide anions (O2
￿-) enzymatically gener-
ated by this system, was evaluated in vitro.T h er e s u l t s
indicate that A. salicina extracts decreased significantly
the XOD-generated superoxide radical with a maximum
decrease at the concentration 50 μg/ml for each extract
(Figure 1). In a previous work, these extracts were found
to be able to decrease the uric acid produced by the
Table 2 Concentration-dependent ABTS free radical scavenging activity of A. salicina leaves extracts and standard
antioxidant Trolox
Extracts
b Concentration (mg/ml) Inhibition (%)
a TEAC (mM) IC50 (mg/mL)
Aqueous extract 0.5 76 ± 1 2.19* 0.24*
2.5 100 ± 2
4.5 100 ± 3
7.5 100 ± 5
9.5 100 ± 2
TOF extract 0.5 100 ± 1 1.92* 0.11*
2.5 100 ± 2
4.5 100 ± 2
7.5 100 ± 1
9.5 100 ± 4
Methanolic extract 0.5 60.7 ± 4.3 1.65* 0.39*
2.5 97.8 ± 3
4.5 99 ± 4
7.5 100 ± 2
9.5 100 ± 1
Trolox
c 0.5 22 ± 1 1 0.76
0.625 32 ± 1
0.833 53.8 ± 2.5
1.25 65 ± 2
2.5 96.8 ± 2.5
* P < 0.05 compared to negative control without the tested extract by student test.
a Inhibition of absorbance at 734 nm relative to that of standart ABTS solution
b Values were expressed as means ± standard deviation of three experiments
c positive control
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were also, able to scavenge superoxide radical generated
by the non-enzymatic system NBT/riboflavin. This
clearly demonstrates that A. salicina extracts provoke
both inhibition of XOD activity and scavenging of super-
oxide anion. These effects are probably mediated by
active components in the extract.
Phenolic compounds present in TOF, methanolic and
aqueous extracts [12] could probably contribute to the
antioxidant potential of extracts, as described previously
by Bouhlel et al [10].
Mutagenic and antimutagenic activities
In experiments, prior to the mutagenicity study, it was
ascertained that the different extracts added to the
inductor bacteria do not influence their viability.
According to Ames et al. [19] and Marques et al. [20]
a compound is classified as a mutagen if it is able to
increase at least twice the number of revertants com-
pared to spontaneous revertants. Based on this, most
mutagenicity assays conducted with extracts were nega-
tive. None of the tested extracts produced a significant
increase of his
+ revertant number of both Salmonella
typhimurium TA 102 and TA 98 strains, in the absence
of the S9 metabolizing system. In fact, mutation fre-
quencies obtained with various concentrations of the
tested samples do not change significantly when com-
pared to spontaneous mutation frequencies. However, in
the presence of S9, a mutagenic effect is observed with
all the tested extracts, in the presence of S. typhimurium
TA98 strain, at the two highest tested doses, and only
with aqueous extract at the highest tested dose in the
S. typhimurium TA 102 assay system. The result of anti-
mutagenic activity in S. typhimurium TA98 assay sys-
tem, is reported in Table 3.
The result of mutagenic activity in S. typhimurium TA
98 and TA102 assays systems is reported in Table 4.
Besides, we envisaged the study of the antimutagenic
activity of the same extracts toward four different muta-
gens, having diverse chemical structures and mode of
actions, by using the Ames assay.
As shown in Table 3, all the extracts prepared from
A. salicina were effective in reducing the mutagenicity
induced by NOPD (10 μg/plate without S9) and MMS
(2.5 mg/plate), a directacting mutagens, in respectively
S. typhimurium TA 98 and TA 102 assay systems. All the
tested extracts showed a clear dose-dependent response.
Compared to methanolic and aqueous extracts, TOF
extract was more effective against both NOPD and MMS
direct mutagens. It reduces their mutagenicity by 99.4%
and 93.5% respectively, at the highest tested dose (500
μg/plate). The possible mechanism of the potent protec-
tion of all the tested extracts against direct mutagens
such as NOPD and MMS could be explained by the
induction of the oxidative defence system and/or DNA
repair enzymes, which are required to protect against
oxidative-like mutations. Teel et al. [21] reported that the
antimutagenic/anticarcinogenic activity of plants may be
due to the interaction of the compounds with target
DNA tissue, which, in turn, blocks the site(s) of DNA to
electropholic attack by reactive mutagenic moieties. In
our case, we speculate that the protective effect of the
extracts against the tested mutagens is probably exerted
by three different ways; firstly, the plant extracts may
adsorb the mutagen in a way similar to the carcinogen
adsorption which has been associated with chemical
component; secondly, extracts could induce
DNA glicosylase enzymes which are capable of repairing
alkylating DNA bases, and finally the reductive ability of
the samples assessed in this study suggests that extracts
were able to donate electrons to free radicals, making the
radicals stable and unreactive [22].
Methanolic, aqueous and TOF extracts reduced the
mutagenicity caused by the indirect mutagen B(a)P (7.5
μg/plate), a metabolically activated genotoxin, using the
S. typhimurium TA 98 strain, in a dose dependent manner
(Table 3). Our results, revealed that TOF extract was the
more potent inhibitor of frame-shift mutations, due to the
lack of a base pair in the GC-pair regions of gene D,
induced by B(a)P in the S. typhimurium TA 98 assay sys-
tem. When we tested at doses of 50, 250 and 500 μg/plate,
all extracts, mixed with 2-AA, showed a toxic effect on
S. typhimurium TA102 cell viability. This effect could be
due to the formation of a complex between the mutagenic
agent (2-AA) and extract components, inducing cell death
at high concentration [22]. Therefore, decreased extract
concentrations to 5, 10 and 25 μg/plate, did not influence
bacterial viability. The tested extracts revealed an inhibi-
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Figure 1 Scavenging effects of extracts of Acacia salicina
against X/XOD-generated superoxide free radicals (O2·
-).
*P<0.05.
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tested dose (5 μg/plate). The result of antimutagenic activ-
ity in S. typhimurium TA102 assay system, is reported in
Table 5.
The inhibitory effects of A. salicina leaf extracts on the
mutagenicity of both direct mutagens (NOPD, MMS)
and metabolically activated mutagens (B(a)P, 2-AA), may
be ascribed to flavonoid and tannin contents of TOF,
methanolic and aqueous extracts [12]. We cannot, how-
ever, exclude the possibility of other compounds, with
antimutagenic properties, participating to the antimuta-
genic effect of A. salicina extracts. The results of our
experiments are consistent with the known antioxidant
activities of flavonoids [23] and tannins [24]. Flavonoids
are the most likely candidates, among the known
compounds, to be present in the TOF-enriched, metha-
nolic and aqueous extracts, involved in the antimutagenic
activity of A. salicina extracts and in preventing oxidative
l e s i o n s[ 2 5 ] .I nt h i ss t u d y ,w eu s e dS. typhimurium
TA102 strain, which is generally selected for specific
detection of the oxidative damages [26]. Thus we suppose
that the constituents A. salicina extracts should inhibit
free radicals and ROS, produced by oxidation and redox-
cycling of both B(a)P and 2- AA, and through reducing
the activity of enzymes involved in B(a)P and 2-AA meta-
bolisation. The extracts may both inhibit microsomal
activation and directly protect DNA from the electrophi-
lic B(a)P epoxide; 7,8-dihydroxy, 9,10-epoxy-7,8,9,10- tet-
rahydrobenzo[a]pyrene, a putative ultimate carcinogenic
metabolite [27]. They may also protect DNA from the
Table 3 Effects of extracts from A. salicina on the mutagenicity induced by NOPD (10 μg/plate) and B(a)P (7.5 μg/







% inhibition of mutagenesis Nb Revertants/plate % inhibition of mutagenesis
Spontaneous - 27 ± 6 - 36 ± 2 -
PC - 723 ± 21 - 122 ± 11 -
Aqueous extract 50 235 ± 11 70.2* 66 65.1*
250 127 ± 10 85.6* 49 84.8*
500 87 ± 09 91.4* 50 83.7*
TOF extract 50 225 ± 08 71.6* 45 89.5*
250 88 ± 06 91.2* 41 94.2*
500 31 ± 03 99.4* 37 97.6*
Methanolic extract 50 207 ± 06 74.2* 65 66.3*
250 122 ± 04 86.4* 61 71*
500 67 ± 05 94.3* 41 95.2*
Positive control (PC): TA98/-S9, NOPD (10 μg/plate); TA98/+S9, B(a)P (7.5 μg/plate).
Table 4 Mutagenic activity of extracts from A. salicina by the S. typhimurium TA98 and TA102 assay systems in the
presence and absence of the metabolic activation system (S9)
TA98 TA102
Extracts Dose (μg/plate) -S9 +S9 -S9 +S9
Spontaneous - 27 ± 6 36 ± 2 175 ± 10 235 ± 12
PC - 723 ± 21 122 ± 11 1721 ± 24 652 ± 10
Aqueous extract 50 22 ± 2 42 ± 4 223 ± 11 387 ± 07
250 24 ± 2 75 ± 5 234 ± 12 398 ± 12
500 24 ± 3 85 ± 5 245 ± 09 477 ± 21
TOF extract 50 23 ± 3 54 ± 8 214 ± 08 345 ± 09
250 25 ± 4 72 ± 10 221 ± 12 354 ± 05
500 29 ± 3 102 ± 13 223 ± 11 377 ± 05
Methanolic extract 50 24 ± 4 44 ± 14 221 ± 10 276 ± 11
250 31 ± 5 74 ± 13 242 ± 05 356 ± 12
500 55 ± 7 95 ± 5 232 ± 08 455 ± 15
Positive control (PC): TA98/-S9, NOPD (10 μg/plate); TA102/-S9, MMS (10 μg/plate); TA98/+S9, B(a)P (7.5 μg/plate); TA102/+S9, 2-AA (5 μg/plate).
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Page 5 of 10electrophilic N-hydroxy-2-aminoanthracene, a metabolite
of 2-AA that interacts with DNA [28] as well as from
other intermediates of the two aforementioned mutagens.
In fact, several metabolic intermediates and ROS formed
during microsomal enzyme activation are also capable of
breaking DNA strands. The antioxidant activity
expressed by A. salicina extracts may provide a common
mechanism for inhibiting the mutagenicity of both B(a)P
and 2-AA. However, the toxic effects obtained with the
highest doses (500, 250 and 50 μg/plate) against S. typhi-
murium TA102 strain, when extracts were combined
with mutagens, can be explained by the presence of
molecules in these extracts which form, with the control
mutagen, complexes with high bactericidal effect. In the
presence of lower doses, probably, a weak number of
molecules should react with 2-AA metabolites giving
minor bactericidal complexes. No lethal effect, against S.
typhimurium TA 102 strain is then detected.
We also noticed that methanolic, aqueous and TOF-
enriched extracts were more efficient in reducing B(a)P
mutagenicity than 2-AA mutagenicity. Curiously, these
extracts exhibited both mutagenic and antimutagenic
activities. We hypothesize tha tt h ep r e s e n c eo fr e a c t i v e
intermediates resulting from both B(a)P and the tested
extracts could result in their mutual neutralization
(antagonist effects). These intermediates may form com-
plexes preventing their penetration through the bacterial
cell wall and thus inhibiting their mutagenic effects [29].
The chemical analysis of leaf extracts from A. salicina,
harvested from the south east of Tunisia [12] revealed
important differences from those obtained from A. salicina
collected from the centre of Tunisia [10,29]. These differ-
ences may explain the different biological activities revealed
by the two A. salicina ecotypifies
On the other hand, our study is in accordance with
results reported by Mansour et al. [12] as far as we con-
firmed the antigenotoxic effect of A. salicina extracts
described by these authors, who used a different prokaryo-
tic assay i.e. the SOS chromotest in the presence of E. Coli
PQ37, described by Quillardet and Hofnung [30]. How-
ever, some differences arised from evaluating O2 .
- scaven-
ging capacity when comparing the antioxydant results of
t h ep r e s e n ts t u d ya n dt h o s er e p o r t e db yB e nM a n s o u r
et al. [12]. They revealed no scavenging effects against
superoxyde anion. This could be explained by the different
antioxydant assays used in each study. In fact, Ben Man-
sour et al. carried out a nonenzymatic O2
. generating sys-
tem to evaluate scavenging effects of A. salicina leaf
Table 5 Effects of extracts from A. salicina on the mutagenicity induced by MMS and 2-AA in S. typhimurium TA102
assay system respectively in the absence and in the presence of S9
TA102
Extracts Dose (μg/plate) -S9 +S9
Nb Revertants/plate % inhibition of mutagenesis Nb Revertants/plate % inhibition of mutagenesis
Spontaneous - 175 ± 10 - 235 ± 12 -
PC - 1721 ± 24 - 652 ± 10 -
Aqueous extract 5 NT NT 600 ± 3 44.6*
10 NT NT 580 ± 8 17
25 NT NT 466 ± 5 12.4
50 477 80.5* T -
250 398 85.6* T -
500 387 86.3* T -
TOF extract 5 NT NT 516 ± 15 32.6*
10 NT NT 520 ± 17 31.6*
25 NT NT 619 ± 14 8
50 377 86.9* T -
250 354 88.4* T -
500 276 93.5* T -
Methanolic extract 5 NT NT 516 ± 9 32.6*
10 NT NT 520 ± 3 31*
25 NT NT 572 ± 9 20
50 455 81.8* T -
250 356 88.3* T -
500 345 89* T -
Nb = number of revertant/plate ± SD; PC = Positive control TA102/-S9, MMS (10 μg/plate); TA102/+S9, 2-AA (5 μg/plate); NT: not tested, T: toxic
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X/XOD superoxide generating assay system to evaluate O2
. scavenging activity of A. salicina extracts.
Conclusion
The results we obtained demonstrate a possible interac-
tion between secondary metabolites from each extract
with the tested radicals, as well as strains used for the and
with the mutagenicity assay. Polar extracts from (Tunisian)
A. salicina leaves exhibited significant radical scavenging
potential as well as antimicrobial and antimutagenic prop-
erties. This work paves the way for studying the effect of
components from this medicinal plant, in the treatment of
cancer cells by eventually inducing apoptotic death.
Methods
Chemicals
Methylmethane sulfonate (MMS), 2-aminoanthracene (2-
AA), Benzo[a]pyrene (B(a)P), 4-nitro-o-phenylenediamine
(NOPD), xanthine (X), xanthine oxidase (XOD), 6-
hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
(Trolox), and 2,2’-azino-bis(3-ethylbenzothiazoline-6-sul-
fonic acid) diammonium salt (ABTS) were obtained from
Sigma Co (St. Louis, USA). Oxoid nutrient broth N°2,
Agar-Agar, yeast extract, bactotryptone were purchased
from Fluka (Buchs, Suisse), histidine and biotine from
Difco (Bordeaux, France). Aroclor 1254 was purchased
from Supelco (Isle d’Abeau Chesnes, France).
Plant materials
A. salicina was collected from the Arid Region Institute
(IRA) situated in the south east of Tunisia, in October
2003. Botanical identification was carried out by Pr.
M. Chaib [31] (Department of Botany, Faculty of Sciences
University of Sfax, Tunisia). A voucher specimen (AS-
10.03) has been kept in the laboratory of Pharmacognosy,
Faculty of Pharmacy of Monastir for future reference. The
leaves were shade-dried, powdered, and stored in a tightly
closed container.
Extraction procedure
The aqueous extract was prepared from 100 g of pow-
dered leaves by boiling in 200 ml water for 15 to 20 min.
The extract was filtered, lyophilised, and the residue was
dissolved in water.
In order to obtain an extract enriched in Total Oligomer
Flavonoids (TOF), we macerated the powdered leaves in
1:2 (v:v) water/acetone for 24 hours with continuous stir-
ring. The extract was filtered and the acetone was evapo-
rated under low pressure in order to obtain an aqueous
solution. The tannins were partially removed by precipita-
tion, with an excess of NaCl, for 24 hours at 5°C, and the
supernatant was recovered. The latter fraction was
extracted with ethyl acetate, followed by concentration
and precipitation with an excess of chloroform. The preci-
pitate was separated and yielded the TOF-enriched
extract.
Methanol extract was obtained from the powdered
leaves with a soxhlet apparatus (4-hours extraction). This
extract was concentrated to dryness and kept at 4°C.
Bacterial strains
Salmonella typhimurium strains TA102 and TA98, a
histidine-requiring mutants, were kindly provided by Pr.
I. Felzenswab, (State University of Rio de Janeiro, Brazil),
and maintained as described by Maron and Ames [32].
The genotypes of the test strains were checked routinely
for their histidine requirement, deep rough (rfa)c h a r a c -
ter and the presence of the R factor. They were stored
at -80°C. S. typhimurium TA98 is a frame-shift sensitive
strain which contains the hisD3052 mutation. It also
contains the plasmid pKM 101, and the products of the
mucAB genes on this plasmid enhance SOS mutagenesis
[26]. S. typhimurium TA102 strain carries the nonsense
mutation hisG428 on the multicopy (30 copies) plasmid
pAQl, over a chromosomal his deletion (TA102).
HisG428 gene contains an A:T base pair at the mutant
site. Strains carrying this mutation can be reverted by
damage at A:T base pairs and by damage at G:C base
pairs as well as by 3, 6 or 9 bp deletions at the mutant
site [26,33,34]. The majority of intragenic base substitu-
tions were A:T- > T:A transversions. Other transitions
and transversions were seen at lower frequencies [26].
Thus the hisG428 mutation can be reverted by all possi-
ble base pair changes as well as by deletions. S. typhi-
murium TA102 strain differs from TA98 strain and the
other standard tester strains, by its intact excision repair
(uvrB+) capacity, which facilitates detection of cross-
linking agents [26].
In vitro antimicrobial activity
The antimicrobial activity of A. salicina extracts was tested
on the Gram-positive bacteria Staphylococcus aureus
ATCC 25923 and Enterococcus faecalis ATCC 29212 as
well as the Gram negative bacteria Escherichia coli ATCC
25922, Salmonella enteretidis ATCC 13076 and Salmo-
nella typhimurium NRRLB 4420, using the microdilution
method [35]. Overnight grown microbial suspensions were
standardized to approximately 10
5 cells/mL [36]. The
microdilution method was used to determine the Mini-
mum Inhibitory Concentrations (MICs) of A. salicina
extracts; 100 μL of microbial suspension containing,
approximately 105 cells/mL, was added to 100 μlo ft h e
extract dilution (concentrations ranging from 62.5 μg/mL
to 10 mg/ml in water). A set of tubes containing only
microbial suspension served as the negative control. These
serially diluted cultures were then incubated at 37°C for
24 hours. Subsequently, 10 μL of each culture was plated
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Page 7 of 10on substance-free Muller-Hinton agar plates and further
incubated at 37°C for 24 hours. MIC was defined as the
lowest concentration of plant extract that completely sup-
presses cell growth. Minimal Bactericidal Concentration
(MBC) was defined as the lowest concentration of extract
that kills 99.99% of the tested bacteria [37].
Radical-scavenging activity on ABTS
+￿
An improved ABTS radical cation decolorization assay
was used. It involves the direct production of the blue/
green ABTS
+￿ chromophore through the reaction
between ABTS and potassium persulfate. Addition of
antioxidants to the preformed radical cation reduces it
to ABTS, to an extent and on a timescale depending on
the antioxidant activity, the concentration of the antioxi-
dant and the duration of the reaction [38]. ABTS was
dissolved in water to a 7 mM concentration. ABTS
+￿
was produced by reacting ABTS stock solution with
2.45 mM potassium persulfate (final concentration) and
allowing the mixture to stay in the dark at room tem-
perature for 12 to 16 hours before use. The ABTS solu-
tion was diluted with ethanol to an absorbance of 0.7 (±
0.02) at 734 nm. In order to measure the antioxidant
activity of extracts, 10 μl of each sample at various con-
centrations (0.5, 2.5, 4.5, 7.5 and 9.5 mg/mL), were
added to 990 μl of diluted ABTS solution and the absor-
bance was recorded every 1 min. We stopped the kinetic
reaction after 30 min. Each concentration was analysed
in triplicate. The percentage decrease of absorbance at
734 nm was calculated for each point and the antioxi-
dant capacity of the test compounds was expressed as
inhibition percent. IC50 value (concentration required
to reduce ABTS
+￿ by 50%) was calculated from a regres-
sion analysis. Trolox is used as a comparison standard
for the determination of the antioxidant activity of a
compound. The results are also reported as Trolox
equivalent antioxidant capacity (TEAC), which is the
molar concentration of Trolox giving the same percen-
tage decrease of ABTS absorbance, as 1 mg/ml of the
antioxidant testing extract, at a specific time point [38].
Superoxide anion Scavenging Activity
The superoxide radical (O2
￿) is a highly toxic species
that is generated by numerous biological and photoche-
mical reactions via the Haber-Weiss reaction. It can
generate the hydroxyl radical, which reacts with DNA
bases, amino acids, proteins, and polyunsaturated fatty
acids, and produces toxic effects. The toxicity of the
superoxide radical could also be due to the perhydroxyl
intermediates (HO2
￿) that react with polyunsaturated
fatty acids. Finally, superoxide may react with NO to
generate peroxynitrite, which is known to be toxic
towards DNA, lipids and proteins.
Xanthine oxidase
In our study, superoxide anion was generated by an
enzymatic X/XOD assay system. The enzyme xanthine
oxidase catalyses the oxidation of xanthine to uric acid.
During this reaction, molecular oxygen acts as an elec-
tron acceptor, producing superoxide radicals according
to the following equation:
Xanthine + O2
Xanthine oxidase
− −−−−−−−−→ Uric acid + O2 +H 2 +H 2O2
The superoxide anion scavenging activity was detected
spectrophotometrically with the nitrite method described
by Oyangagui [39] with some modifications introduced
b yH ue ta l .[ 4 0 ]a n dR u s s oe ta l .[ 4 1 ] .B r i e f l y ,t h ea s s a y
mixture consisted of 100 μL of the tested compound
solution, 200 μL of xanthine (final concentration 50 μM)
as the substrate, hydroxylamine (final concentration
0.2 mM), 200 μL of Ethylenediaminetetraacetic acid
(EDTA) (0.1 mM) and 300 μL of distilled water. The
reaction was initiated by adding 200 μlo fX O D( 1 1m U )
dissolved in phosphate buffer (KH2PO4 20.8 mM, pH
7.5). The assay mixture was incubated at 37°C for
30 min. The reaction was stopped by adding 0.1 mL of
HCl 0.5 M. Another control solution without the tested
compound was prepared in the same manner as the assay
mixture, to measure the total uric acid production
(100%). To detect the superoxide scavenging activity,
2 mL of the colouring reagent consisting of sulphanilic
acid solution (final concentration 300 μg/mL), N-(1-
naphtyl) ethylenediamine dihydrochloride (final concen-
tration 5 μg/mL) and acetic acid (16.7%, v/v) were added.
This mixture was allowed to rest for 30 min at room
temperature and the absorbance was measured spectro-
photometrically at 550 nm. The absorbance was mea-
sured against a blank solution prepared as described
above, but replacing XOD with buffer solution. The
dose-effect curve for each test compound was linearized
by a regression analysis and used to derive the IC50
values.
Activation mixture
The S9 microsome fraction was prepared from rats trea-
ted with Aroclor 1254 [32]. The components of S9 mix
w e r e1m Lo fs a l ts o l u t i o n ;0 . 2 5m lo f1Mg l u c o s e6
p h o s p h a t e ;2m lo f0 . 1MN A D P ;2 5m lo f0 . 2Ms o d i u m
phosphate buffer, pH 7.4; 7 mL of S9 microsome fraction
and 14.75 mL H2O. The S9 mix was prepared freshly for
each assay [32]. Protein concentration of S9 was deter-
m i n e du s i n gp r o t e i nB i o R a da s s a y[ 4 2 ] ,i tw a sf o u n dt o
be 12.3 mg/mL.
Salmonella-microsome assay
The mutagenicity assay with Salmonella typhimurium
was performed as described by Maron and Ames [32].
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exogenous metabolic system, the S9 fraction in S9 mix.
We added 100 μL of bacterial exponential-phase culture
and 500 μL of S9 mix for assay with S9, or 500 μLo f
sodium phosphate buffer (0.2 M, pH 7.4 for assay with-
out S9) to 2 ml aliquots of top agar (supplemented with
0.5 mM L-histidine and 0.5 mM d-biotin), containing
100 μL of different concentrations of each tested extract.
The resulting complete mixture was poured on minimal
agar plates prepared as described by Maron and Ames
[32]. The plates were incubated at 37°C for 48 hours
and the revertant bacterial colonies of each plate were
counted. The negative and positive control cultures gave
numbers of revertants per plate that were within the
normal limits found in the laboratory. An extract was
considered mutagenic if the number of revertants per
plate was at least doubling in S. typhimurium TA102
and TA98 strains over the spontaneous revertant fre-
quencies [19,20]. The appropriate positive controls
accepted for the Ames test were applied; these controls
were selected according to the type of strain used, and
the presence or absence of the S9 mix.
Data were collected with a mean ± standard deviation
of three plates (n = 3).
Antimutagenicity testing
The test was performed using the preincubation method
to 0.5 ml of S9 mixture when using the indirect mutagens
2-AA (5 μg/plate) and B(a)P (7.5 μg/plate), or 0.5 mL of
phosphate buffer (when using the direct mutagens MMS
(10 μg/plate) and NOPD (10 μg/plate)). We added 0.1 mL
of the test compounds (50 μL of mutagen and/or 50 μLo f
test compound) and 0.1 mL of bacterial culture (prepared
as described in mutagenicity test). After vortexing gently
and preincubating at 45°C for 30 min, 2 ml of top agar
supplemented with 0.05 M Lhistidine and D-biotine were
added to the mixture and vortexed for 3 s. The resulting
entire was overlaid on a minimal agar plate. The plates
were incubated at 37°C for 48 h and the revertant bacterial
colonies on each plate were counted. The inhibition rate
of mutagenicity (%) was calculated relative to those in the
control group with the mutagen by the following formula:
percent inhibition (%) = [1 - ((number of revertants on
test plates - number of spontaneous revertants)/(number
of revertants on positive control plates - number of spon-
taneous revertants))] × 100. Each dose was tested in
triplicate.
Statistical analyses
Data were collected and expressed as the mean ± standard
deviation of three independent experiments and analyzed
for statistical significance from control. The data were
tested for statistical differences by student test. The criter-
ion for significance was set at p < 0.05.
Abbreviations
A. salicina: Acacia salicina; B(a)P: Benzo[a]pyrene; rfa: Deep rough; E. faecalis:
Enterococcus faecalis; E. coli: Escherichia coli; MMS: Methylmethane sulfonate;
MIC: Minimum Inhibitory Concentrations; MBC: Minimal bactericidal
concentration; TOF: Total Oligomer Flavonoids; TEAC: Trolox Equivalent
Antioxidant Capacity; S. typhimurium: Salmonella typhimurium; S. aureus:
Staphylococcus aureus; S. entretidis: Salmonella entretidis; S. typhimurium:
Salmonella typhimurium; X/XOD: Xanthine/xanthine oxidase; X: Xanthine; XOD:
xanthine oxidase; 2-AA: 2-aminoanthracene; NOPD: 4-nitro-o-
phenylenediamine; ABTS: 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
diammonium salt; Trolox: 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic
acid.
Acknowledgements
We acknowledge the “ Ministère Tunisien de l’Enseignement Supèrieur, de la
Recherche et de la Technologie “ for the support of this study and Mr. Samir
Boukattaya (Pr. of English at the Faculty of Dental Medicine, Tunisia) for
English editing.
Author details
1Laboratory of Cellular and Molecular Biology, Faculty of Dental Medicine,
University of Monastir, Rue Avicenne, Monastir 5000, Tunisia.
2Unity of
Pharmacognosy/Molecular Biology, Faculty of Pharmacy, University of
Monastir, Rue Avicenne, Monastir 5000, Tunisia.
3Department of Cellular and
Molecular Biology, Faculty of Dental Medicine, Rue Avicenne, 5000 Monastir,
Tunisia.
Authors’ contributions
JB: Was responsible for the conception and design, testing and data
acquisition, analysis and data interpretation and drafted the manuscript.
HBM: Was responsible for the conception and design, testing and data
acquisition, analysis and data interpretation and drafted the manuscript. The
two authors have equally contributed to this work. KG: made
substantial contribution to conception and revised it critically for important
intellectual content. LCG: made substantial contribution to conception and
revised it critically for important intellectual content. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 3 September 2011 Accepted: 10 April 2012
Published: 10 April 2012
References
1. Swayamjot K, Husheem M, Saroj A, Pirkko LH, Subodh-Kumar K: The in vitro
cytotoxic and apoptotic activity of Triphala-an Indian herbal drug. J
Ethnopharmacol 2005, 97:15-20.
2. Wadood A, Wadood N, Wahid-Shah SA: Effects of Acacia arabica and
Caralluma edulis on blood glucose levels of normal and alloxan diabetic
rabbits. J Pak Med Assoc 1989, 39:208-212.
3. Sotohy SA, Sayed AN, Ahmed MM: Effect of tannin-rich plant (Accacia
nilotica) on some nutritional and bacteriological parameters in goats.
Deutsche Tierarztliche Wochenschrift 1997, 104:432-435.
4. Dafallah AA, Al-Mustapha Z: Investigation of the anti-inflammatory
activity of Acacia nilotica and Hibiscus sabdariffa. Am J Chinese Med 1996,
24:263-269.
5. Ghosh NK, Babu SP, Sukul NC, Ito A: Cestocidal activity of Acacia
auriculiformis. J of Helmintol 1996, 70:171-172.
6. Amos S, Akah PA, Odukwe CJ, Gamaniel KS, Wambede C: The
pharmacological effects of an aqueous extract from Acacia nilotica
seeds. Phytother Res 1999, 13:683-685.
7. Gilani AH, Shaheen F, Zaman M, Janbaz KH, Shah BH, Akhtar MS: Studies
on hypertensive and antispasmodic activities of methanol extract of
Acacia nilotica pods. Phytother Res 1999, 14:510-516.
8. Shah BH, Safdar B, Virani SS, Nawaz Z, Saeed SA, Gilani AH: The antiplatelet
aggregatory activityof Accacia nilotica is due to blockage of calcium influx
through membrane calcium channels. General Pharmacol 1997, 29:251-255.
9. Hussein G, Miyashiro H, Nakamura N, Hattori M, Kakiuchi N, Shimotohno K:
Inhibitory effects of Sudanese medicinale plant eextracts on hepatitis C
virus (HCV). Phytother Res 2000, 14:510-516.
Boubaker et al. BMC Complementary and Alternative Medicine 2012, 12:37
http://www.biomedcentral.com/1472-6882/12/37
Page 9 of 1010. Bouhlel I, Valenti K, Kilani S, Skandrani I, Sghaier MB: Antimutagenic,
antigenotoxic and antioxidant activities of Acacia salicina extracts (ASE)
and modulation of cell gene expression by H2O2 and ASE treatment. TIV
2008, 2008(22):1264-1272.
11. Getachew G, Makkar HP, Becker : Tannins in tropical browses: effects on
in vitro microbial fermentation and microbial protein synthesis in media
containing different amounts of nitrogen. J Agric Food Chem 2000,
48:3581-3588.
12. Ben-Mansour H, Boubaker J, Bouhlel I, Mahmoud A, Bernillon S, Ben-
Chibani J, Ghedira K, Chekir-Ghedira L: Antigenotoxic activities of crude
extracts from Acacia salicina leaves. Environ Mol Mutagen 2007, 48:58-66.
13. Chiang LC, Chiang W, Liu MC, Lin CC: In vitro antiviral activities of
Caesalpinia pulcherrima and its related flavonoids. J Antimicrob Chemother
2003, 52:194-198.
14. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM,
Tauxe RV: Food-related illness and death in the United States. Emerg
Infect Dis 1999, 5:607-625.
15. O’Brien SJ, de Valk H: Salmonella-"old” organism, continued challenges!
Eurosurveillance 2003, 8:29-31.
16. Dhidah M, Trabelsi A, Mazoughi R, Dhidah L, Boujaafar N, Jeddi M:
Salmonella and salmonelloses in the region of Sousse (Tunisia). Microbiol
Hyg Alim 1995, 19:3-7.
17. Van der Berg R, Haenen GRMM, Van der Berg H, Van den Vijgh W, Bast A:
The predictive value of the antioxidant capacity of structurally related
flavonoids using the Trolox equivalent antioxidant capacity (TEAC) assay.
Food Chem 2000, 70:391-395.
18. Villaño D, Fernãndez-Pachõn MS, Troncoso AM, Garciã-Parrilla MC: The
antioxidant activity of wines determined by the ABTS+￿ method:
influence of sample dilution and time. Talanta 2004, 64:501-509.
19. Ames BN, McCann J, Yamasaki E: Methods for detecting carcinogens and
mutagens with the Salmonella/mammalian microsome mutagenicity
test. Mut Res 1975, 31:347-364.
20. Marques RCP, de Medeiros SRB, da Silva Dias C, Barbosa-Filho JM, Agnez-
Lima LF: Evaluation of the mutagenic potential of yangambin and of the
hydroalcoholic extract of Ocotea duckei by the Ames test. Mutat Res
2003, 536:117-120.
21. Teel RW: Ellargic acid binding to DNA as a possible mechanism for its
antimutagenic and anticarcinogenic action. Cancer Letter 1986,
30:329-336.
22. Boubaker J, Skandrani I, Bouhlel I, Ben Sghaier M, Neffati A, Ghedira K,
Chekir-Ghedira L: Mutagenic, antimutagenic and antioxidant potency of
leaf extracts from Nitraria retusa. Food and Chem Toxicol 2010,
48:2283-2290.
23. Vaya J, Mohmod S, Goldblum A, Aviram M, Volkavor N, Shaalam A, Musa R,
Tamir S: Inhibition of LDL oxidation by flavonoïds in relation to their
structure and calculated enthalpy. Phytochem 2003, 62:89-99.
24. Zoran M, Dorde M, Nada K: Polyphenol contents and antioxidant activity
of Maydis stigma extracts. Biores. Technol 2005, 96:873-877.
25. Edenharder R, Grunhage D: Free radical scavenging abilities of flavonoids
as mechanism of protection against mutagenicity induced by test-butyl
hydroperoxide or cumene hydroperoxide in Salmonella typhimurium TA
102. Mutat Res 2003, 540:1-18.
26. Levin DE, Hollstein M, Christman MF, Schwiers EA, Ames BN: A new
Salmonella tester strain (TA102) with A.T base pairs at the site of
mutation detects oxidative mutagens. Proc Natl Acad Sci USA 1982,
79:7445-7449.
27. Harris CC, Vähäkangas K, Newman MJ, Trivers GE, Shamsuddin A, Sinopoli N,
Mann DL, Wright WE: Detection of benzo[a]pyrene diol epoxide-DNA
adducts in peripheral blood lymphocytes and antibodies to the adducts
in serum from coke oven workers. Proc Natl Acad Sci USA 1985,
82:6672-6676.
28. Horn RC, Ferrao VVM: Antimutagenic activity of extracts of natural
substances in the Salmonella microsome assay. Mutag 2003, 18:113-118.
29. Bouhlel I, Ben Mansour H, Limem I, Ben Sghaier M, Mahmoud A, Ben
Chibani J, Ghedira K, Chekir-Ghedira L: Screening of antimutagenicity via
antioxidant activity in different extracts from the leaves of Acacia
salicina from the center of Tunisia. Environm Toxicol Pharmacol 2007,
23:56-63.
30. Quillardet PQ, Hofnung M: The SOS Chromotest colorimetric bacterial
assay for genotoxins: Procedures. Mutat Res 1985, 147:65-78.
31. Chaib M, Boukhris M: Flore succinct et illustré des zones arides et
sahariennes de Tunisie. 1998, 43-44.
32. Maron DM, Ames BN: Revised methods for the Salmonella mutagenicity
test. Mutat Res 1983, 113:173-215.
33. Hartman PE, Ames BN, Roth JR, Branes WN, Levin DE: Target sequences for
mutagenesis in Salmonella histidine-requiring mutants. Environ Mol
Mutagen 1986, 8:631-641.
34. Koch WH, Henrikson EN, Cebula TA: Molecular analyses of Salmonella
hisG428 ochre revertants for rapid characterization of mutational
specificity. Mutagenesis 1996, 11:341-348.
35. Hayder N, Abdelwahed A, Kilani S, Ammar RB, Mahmoud A, Ghedira K,
ChekirGhedira L: Anti-genotoxic and free-radical scavenging activities of
extracts from (Tunisian) Myrtus communis. Mut Res 2004, 564:89-95.
36. Cremieux A, Fleurette J: Methods of testing disinfectants. In disinfection,
sterilization and preservation. Lea and Febiger, Philadelphia and London;,
4 1991, 1009-1027.
37. Ben Ammar R, Kilani S, Bouhlel I, Skandrani I, Naffeti A, Boubaker J, Ben
Sghaier M, Bhouri W, Mahmoud A, Chekir L, Ghedira K: Antibacterial and
cytotoxic activities of extracts from (Tunisian) Rhamnus alaternus
(Rhamnaceae). Ann Microbio 2007, 57:453-460.
38. Re P, Proteggente R, Pannala N, Yang A, Rice-Evans CMA: Antioxidant
activity applying an improved ABTS radical cation decolorization assay.
Free Radic Biol Med 1999, 26:1231-1237.
39. Oyangagui Y: Reevaluation of assay methods and establishment of kit
for superoxide dimutase activity. Analy Biochem 1984, 142:290-296.
40. Hu JP, Calomme M, Lasure A, De Bruyne T, Pieters L, Vlietinck A, Vanden
Berghe DA: Structure activity relationship of flavonoids with superoxide
scavenging activity. Biol. Trace Elem Res 1995, 47:327-331.
41. Russo A, Cardile V, Lombardo L, Vanella L, Vanella A, Garbarino JA:
Antioxidant and antiproliferative action of methanolic extract of Geum
Quellyon sweet roots in human tumor cell lines. Journal of Ethnopharma
2005, 100:323-332.
42. Bradford MM: A Rapid and Sensitive Method for the Quantitation of
Microgram Quantities of Protein Utilizing the Principle of Protein-Dye
Binding. Annals Biochemestry 1976, 72:248-254.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6882/12/37/prepub
doi:10.1186/1472-6882-12-37
Cite this article as: Boubaker et al.: Polar extracts from (Tunisian) Acacia
salicina Lindl. Study of the antimicrobial and antigenotoxic activities.
BMC Complementary and Alternative Medicine 2012 12:37.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Boubaker et al. BMC Complementary and Alternative Medicine 2012, 12:37
http://www.biomedcentral.com/1472-6882/12/37
Page 10 of 10